The Minister was welcomed by Dr. Ravi Edirisinghe, Group CEO of LAUGFS Holdings, Dr. Rajiv Perera, CEO of LAUGFS Life Sciences, and senior leadership teams. He was given a tour of the facility’s advanced sterile infusion production lines, where LAUGFS is preparing to introduce Large Volume Parenterals (LVPs) using Euro Multiport systems and Form-Fill-Seal technology; globally recognised methods that ensure safety, sterility, and efficiency.
Dr. Jayatissa commended the initiative, noting that such investments enhance local production, reduce reliance on imports, and deliver high-quality, affordable solutions for both public and private healthcare sectors. He also emphasised the vital role of public-private partnerships in strengthening national healthcare resilience.
Through LAUGFS Life Sciences, the Group continues to invest in innovation, regulatory excellence, and advanced pharmaceutical technologies, positioning Sri Lanka as a regional hub for infusion therapy solutions while creating long-term value for the nation
